Royal Bank Of Canada Heska Corp Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$62.17 - $97.62 $611,628 - $960,385	9,838 Added 43.19%	32,617 $3.18 Million
Q4 2022 Feb 14, 2023	BUY	$60.21 - $77.74 $144,624 - $186,731	2,402 Added 11.79%	22,779 $1.42 Million
Q3 2022 Nov 14, 2022	SELL	$72.92 - $99.73 $230,718 - $315,545	-3,164 Reduced 13.44%	20,377 $1.49 Million
Q2 2022 Aug 15, 2022	BUY	$84.23 - $147.57 $55,507 - $97,248	659 Added 2.88%	23,541 $2.22 Million
Q1 2022 May 16, 2022	BUY	$122.89 - $171.74 $309,314 - $432,269	2,517 Added 12.36%	22,882 $3.16 Million
Q4 2021 Feb 14, 2022	BUY	$156.0 - $265.78 $169,728 - $289,168	1,088 Added 5.64%	20,365 $3.72 Million
Q3 2021 Nov 15, 2021	BUY	$228.69 - $274.2 $229,833 - $275,571	1,005 Added 5.5%	19,277 $4.98 Million
Q2 2021 Aug 16, 2021	BUY	$169.89 - $231.37 $3.1 Million - $4.23 Million	18,272 New	18,272 $4.2 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.